• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Cell Rep . Differences in syncytia formation by SARS-CoV-2 variants modify host chromatin accessibility and cellular senescence via TP53

tetano

Editor, Senior Moderator
Cell Rep


. 2023 Nov 21;42(12):113478.
doi: 10.1016/j.celrep.2023.113478. Online ahead of print. Differences in syncytia formation by SARS-CoV-2 variants modify host chromatin accessibility and cellular senescence via TP53

Jonathan D Lee[SUP] 1 [/SUP], Bridget L Menasche[SUP] 2 [/SUP], Maria Mavrikaki[SUP] 3 [/SUP], Madison M Uyemura[SUP] 3 [/SUP], Su Min Hong[SUP] 4 [/SUP], Nina Kozlova[SUP] 4 [/SUP], Jin Wei[SUP] 2 [/SUP], Mia M Alfajaro[SUP] 2 [/SUP], Renata B Filler[SUP] 2 [/SUP], Arne Müller[SUP] 3 [/SUP], Tanvi Saxena[SUP] 3 [/SUP], Ryan R Posey[SUP] 5 [/SUP], Priscilla Cheung[SUP] 6 [/SUP], Taru Muranen[SUP] 4 [/SUP], Yujing J Heng[SUP] 3 [/SUP], Joao A Paulo[SUP] 7 [/SUP], Craig B Wilen[SUP] 2 [/SUP], Frank J Slack[SUP] 8 [/SUP]



Affiliations
Abstract

Coronavirus disease 2019 (COVID-19) remains a significant public health threat due to the ability of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants to evade the immune system and cause breakthrough infections. Although pathogenic coronaviruses such as SARS-CoV-2 and Middle East respiratory syndrome (MERS)-CoV lead to severe respiratory infections, how these viruses affect the chromatin proteomic composition upon infection remains largely uncharacterized. Here, we use our recently developed integrative DNA And Protein Tagging methodology to identify changes in host chromatin accessibility states and chromatin proteomic composition upon infection with pathogenic coronaviruses. SARS-CoV-2 infection induces TP53 stabilization on chromatin, which contributes to its host cytopathic effect. We mapped this TP53 stabilization to the SARS-CoV-2 spike and its propensity to form syncytia, a consequence of cell-cell fusion. Differences in SARS-CoV-2 spike variant-induced syncytia formation modify chromatin accessibility, cellular senescence, and inflammatory cytokine release via TP53. Our findings suggest that differences in syncytia formation alter senescence-associated inflammation, which varies among SARS-CoV-2 variants.

Keywords: ATAC-seq; COVID-19; CP: Immunology; SARS-CoV-2; chromatin; iDAPT-MS; p53; proteomics; senescence; spike.

 
Back
Top Bottom